Login to Your Account

Additional $25M in Milestones

Cornerstone Diversifies Hospital Portfolio, Buys EKR for $125M

By Marie Powers
Staff Writer

Wednesday, May 16, 2012
Cornerstone Therapeutics Inc., which has taken some interesting turns on the road to building a portfolio of hospital and respiratory products, expanded its acute care franchise with an agreement to acquire EKR Therapeutics Inc., which specializes in drugs used in the critical care setting.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription